產品名稱 |
EL4.IL-2 |
商品貨號 |
B164407 |
Organism |
Mus musculus, mouse |
Tissue |
thymus |
Product Format |
frozen |
Morphology |
lymphoblast |
Culture Properties |
suspension |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
lymphoma |
Strain |
C57BL/6 |
Storage Conditions |
liquid nitrogen vapor phase |
Genes Expressed |
interleukin-2 (interleukin 2, IL-2) |
Cellular Products |
interleukin-2 (interleukin 2, IL-2) |
Comments |
This is a subline of EL4 (ATCC TIB-39) that produces IL-2 in response to phorbol-12-myristate-13-acetate (PMA). The line is capable of producing 2500 units/ml of IL-2 after 24 hours in culture with PMA. Tested and found negative for ectromelia virus (mousepox). |
Complete Growth Medium |
The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: horse serum to a final concentration of 10%.
|
Subculturing |
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 105 viable cells/mL. Maintain cell density between 1 to 2 X 106 viable cells/mL.
Medium Renewal: Every 2 to 3 days |
Cryopreservation |
Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO Storage temperature: liquid nitrogen vapor phase |
Culture Conditions |
Temperature: 37°C |
Name of Depositor |
JJ Farrar |
Deposited As |
Mus musculus |
References |
Farrar JJ, et al. Thymoma production of T cell growth factor (interleukin-2). J. Immunol. 125: 2555-2558, 1980. PubMed: 6968789
Cancer therapeutics. New York: Raven Press; 1981.
Fuller-Farrar J, et al. Phorbol myristic acetate enhances the production of interleukin 2. Cell. Immunol. 58: 156-164, 1981. PubMed: 6784931
|